Email This Story
Print This StoryCalifornia Company Signs Stem Cell Deal With WARF
Company Plans To Develop Products To Help Scientists
UPDATED: 11:42 am CST January 9,
2008
MADISON, Wis. -- A California company hopes to use stem cell technology developed at the University of Wisconsin-Madison to make new medical and research products.BioTime Inc. has signed a licensing agreement with the Wisconsin Alumni Research Foundation (WARF) to use 173 patents and patent applications covering human embryonic stem cell technology.The patents cover some of the work of UW-Madison scientist James Thomson.Embryonic stem cells can turn into any type of cell in the body, and BioTime plans to develop products that help scientists do that.CEO Michael West said that the cells could then be used in research for cures to disease and to develop new drugs.
Previous Stories:
- December 6, 2007: UW-Madison Wants NIH To Fund New Stem Cell Research Technique
- November 21, 2007: WisBusiness: Leaders Say Stem Cell Breakthrough Could Bring Jobs To State
- November 21, 2007: UW, Japanese Scientists Report Stem Cell Breakthrough
- October 20, 2007: WisBusiness: Stemina CEO Predicts Next President Will Increase Stem Cell Funding
- September 7, 2007: National Stem Cell Bank Obtains More Cell Lines
- August 6, 2007: Patent Fight Could Tarnish Reputation Of Stem Cell Pioneer
- July 19, 2007: Science Camp Offers Students Experience With Stem Cells
- July 13, 2007: WisBusiness: Experts Say Stem Cell Research Needs Biz Community Support
Copyright 2008 by Channel 3000. The Associated Press contributed to this report. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
